Influence of donor and recipient gender on liver transplantation outcomes in Europe.


Journal

Liver international : official journal of the International Association for the Study of the Liver
ISSN: 1478-3231
Titre abrégé: Liver Int
Pays: United States
ID NLM: 101160857

Informations de publication

Date de publication:
08 2020
Historique:
received: 05 03 2020
revised: 21 04 2020
accepted: 06 05 2020
pubmed: 18 5 2020
medline: 22 6 2021
entrez: 18 5 2020
Statut: ppublish

Résumé

The impact of gender and donor/recipient gender mismatch on LT outcomes is controversial. The aim of this study was to compare outcomes of LT in Europe, using the ELTR database, between male and female recipients, including donor/recipient gender mismatch. Recipient, donor and transplant characteristics were compared between male and female patients. Patient survival was compared between groups, and the impact of donor/recipient gender matching as well as donor and recipient anthropometric characteristics were evaluated as potential risk factors for post-LT death/graft loss. A total of 46,334 LT patients were evaluated (70.5% men and 29.5% women). Ten-year survival rate was significantly higher in female than in male recipients (66% vs 59%, P < .0001). At multivariate analysis, adjusted for indication to LT and type of graft, donor/recipient gender mismatch (HR 1.12, 95% CI 1.04-1.2; P = .003), donor age > 60 years (HR 1.09, 95% CI 1.01-1.18; P = .027) and recipient age (HR 1.02, 95% CI 1.1-1.02; P < .0001) were significantly associated with post-LT lower survival rate in men. Conversely in female recipients, donor BMI > 30 (HR 1.32, 95% CI 1.09-1.6; P = .005), donor age > 60 years (HR 1.15, 95% CI 1.01-1.32; P = .027) and recipient age (HR 1.02, 95% CI 1.01-1.02; P < .0001) were significantly associated with lower post-LT survival rate. Donor/recipient gender mismatch in male recipients and the use of obese donor in female recipients are associated with reduced survival after LT. Therefore, the incorporation of donor and recipient anthropometric quantities in the allocation process should be a matter of further studies, as their matching can significantly influence long-term outcomes.

Sections du résumé

BACKGROUND & AIMS
The impact of gender and donor/recipient gender mismatch on LT outcomes is controversial. The aim of this study was to compare outcomes of LT in Europe, using the ELTR database, between male and female recipients, including donor/recipient gender mismatch.
METHODS
Recipient, donor and transplant characteristics were compared between male and female patients. Patient survival was compared between groups, and the impact of donor/recipient gender matching as well as donor and recipient anthropometric characteristics were evaluated as potential risk factors for post-LT death/graft loss.
RESULTS
A total of 46,334 LT patients were evaluated (70.5% men and 29.5% women). Ten-year survival rate was significantly higher in female than in male recipients (66% vs 59%, P < .0001). At multivariate analysis, adjusted for indication to LT and type of graft, donor/recipient gender mismatch (HR 1.12, 95% CI 1.04-1.2; P = .003), donor age > 60 years (HR 1.09, 95% CI 1.01-1.18; P = .027) and recipient age (HR 1.02, 95% CI 1.1-1.02; P < .0001) were significantly associated with post-LT lower survival rate in men. Conversely in female recipients, donor BMI > 30 (HR 1.32, 95% CI 1.09-1.6; P = .005), donor age > 60 years (HR 1.15, 95% CI 1.01-1.32; P = .027) and recipient age (HR 1.02, 95% CI 1.01-1.02; P < .0001) were significantly associated with lower post-LT survival rate.
CONCLUSIONS
Donor/recipient gender mismatch in male recipients and the use of obese donor in female recipients are associated with reduced survival after LT. Therefore, the incorporation of donor and recipient anthropometric quantities in the allocation process should be a matter of further studies, as their matching can significantly influence long-term outcomes.

Identifiants

pubmed: 32418358
doi: 10.1111/liv.14510
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1961-1971

Informations de copyright

© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

Adam R, Karam V, Delvart V, et al. Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR). J Hepatol. 2012;57:675-688.
Briceno J, Ciria R, de la Mata M. Donor-recipient matching: myths and realities. J Hepatol. 2013;58:811-820.
Sarkar M, Watt KD, Terrault N, Berenguer M. Outcomes in liver transplantation: does sex matter? J Hepatol. 2015;62:946-955.
Rodriguez-Castro KI, De Martin E, Gambato M, Lazzaro S, Villa E, Burra P. Female gender in the setting of liver transplantation. World J Transplant. 2014;4:229-242.
Burra P, De Martin E, Gitto S, Villa E. Influence of age and gender before and after liver transplantation. Liver Transpl. 2013;19:122-134.
Axelrod DA, Pomfret EA. Race and sex disparities in liver transplantation: progress toward achieving equal access? JAMA. 2008;300:2425-2426.
Mathur AK, Schaubel DE, Gong Q, Guidinger MK, Merion RM. Sex-based disparities in liver transplant rates in the United States. Am J Transplant. 2011;11:1435-1443.
Marino IR, Doyle HR, Aldrighetti L, et al. Effect of donor age and sex on the outcome of liver transplantation. Hepatology. 1995;22:1754-1762.
Rustgi SD, Marino G, Halpern MT, Umana WO, Tolleris C, Rustgi VK. Impact of donor age on graft survival among liver transplant recipients: analysis of the United Network for Organ Sharing database. Transplant Proc. 2002;34:3295-3297.
Velidedeoglu E, Mange KC, Frank A, et al. Factors differentially correlated with the outcome of liver transplantation in hcv+ and HCV− recipients. Transplantation. 2004;77:1834-1842.
Lehner F, Becker T, Klempnauer J, Borlak J. Gender-incompatible liver transplantation is not a risk factor for patient survival. Liver Int. 2009;29:196-202.
Karam V, Gunson B, Roggen F, et al. Quality control of the European Liver Transplant Registry: results of audit visits to the contributing centers. Transplantation. 2003;75:2167-2173.
https://optn.transplant.hrsa.gov. In.
Vercelli M, Lillini R, Quaglia A, Micale RT, La Maestra S, De Flora S. Age-related mortality trends in Italy from 1901 to 2008. PLoS One. 2014;9:e114027.
http://www.eltr.org
Brooks BK, Levy MF, Jennings LW, et al. Influence of donor and recipient gender on the outcome of liver transplantation. Transplantation. 1996;62:1784-1787.
Francavilla R, Hadzic N, Heaton ND, et al. Gender matching and outcome after pediatric liver transplantation. Transplantation. 1998;66:602-605.
Croome KP, Segal D, Hernandez-Alejandro R, Adams PC, Thomson A, Chandok N. Female donor to male recipient gender discordance results in inferior graft survival: a prospective study of 1,042 liver transplants. J Hepatobiliary Pancreat Sci. 2014;21:269-274.
Schoening WN, Helbig M, Buescher N, et al. Gender Matches in Liver Transplant Allocation: matched and mismatched male-female donor-recipient combinations; long-term follow-up of more than 2000 patients at a single center. Exp Clin Transplant. 2016;14:184-190.
Lai Q, Giovanardi F, Melandro F, et al. Donor-to-recipient gender match in liver transplantation: a systematic review and meta-analysis. World J Gastroenterol. 2018;24:2203-2210.
Francavilla A, Di Leo A, Eagon PK, et al. Regenerating rat liver: correlations between estrogen receptor localization and deoxyribonucleic acid synthesis. Gastroenterology. 1984;86:552-557.
Alvaro D, Mancino MG, Onori P, et al. Estrogens and the pathophysiology of the biliary tree. World J Gastroenterol. 2006;12:3537-3545.
Yoshizumi T, Taketomi A, Uchiyama H, et al. Graft size, donor age, and patient status are the indicators of early graft function after living donor liver transplantation. Liver Transpl. 2008;14:1007-1013.
Firl DJ, Hashimoto K, O'Rourke C, et al. Role of donor hemodynamic trajectory in determining graft survival in liver transplantation from donation after circulatory death donors. Liver Transpl. 2016;22:1469-1481.
Andert A, Becker N, Ulmer F, et al. Liver transplantation and donor body mass index >30: use or refuse? Ann Transplant. 2016;21:185-193.
Molina Raya A, Vilchez Rabelo A, Dominguez Bastante M, Fundora Suarez Y. Influence of donor obesity on long-term liver transplantation outcomes. Transplant Proc. 2019;51:62-66.
Yoo HY, Molmenti E, Thuluvath PJ. The effect of donor body mass index on primary graft nonfunction, retransplantation rate, and early graft and patient survival after liver transplantation. Liver Transpl. 2003;9:72-78.
Glanemann M, Langrehr JM, Stange BJ, et al. Clinical implications of hepatic preservation injury after adult liver transplantation. Am J Transplant. 2003;3:1003-1009.
Leithead JA, Rajoriya N, Gunson BK, Muiesan P, Ferguson JW. The evolving use of higher risk grafts is associated with an increased incidence of acute kidney injury after liver transplantation. J Hepatol. 2014;60:1180-1186.

Auteurs

Giacomo Germani (G)

Multivisceral Transplant Unit, Department of Surgery, Oncology and Gastroenterology, Padua University Hospital, Padua, Italy.

Nicola Zeni (N)

Multivisceral Transplant Unit, Department of Surgery, Oncology and Gastroenterology, Padua University Hospital, Padua, Italy.

Alberto Zanetto (A)

Multivisceral Transplant Unit, Department of Surgery, Oncology and Gastroenterology, Padua University Hospital, Padua, Italy.

René Adam (R)

ELTR, Assistance Publique-Hôpitaux de Paris, Hôpital Paul Brousse, Centre Hepato-Biliaire, Universite´Paris-Sud, Villejuif, France.

Vincent Karam (V)

ELTR, Assistance Publique-Hôpitaux de Paris, Hôpital Paul Brousse, Centre Hepato-Biliaire, Universite´Paris-Sud, Villejuif, France.

Luca S Belli (LS)

Gastroenterology and Hepatology, Liver Unit, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.

John O'Grady (J)

King's College Hospital, London, UK.

Darius Mirza (D)

The Queen Elizabeth Hospital, Birmingham, UK.

Jurgen Klempnauer (J)

Medizinische Hochschule Hannover, Hannover, Germany.

Daniel Cherqui (D)

Paul Brousse Hospital, Villejuif, France.

Johann Pratschke (J)

Charité - Campus - Virchow Klinikum, Berlin, Germany.

Neville Jamieson (N)

Addenbrooke's Hospital, Cambridge, UK.

Mauro Salizzoni (M)

Centro de Trapianti di Fegato, Torino, Italy.

Ernest Hidalgo (E)

St. Jame's & Seacroft University Hospital, Leeds, UK.

Jan Lerut (J)

Universitè Catholique Louvain, Brussels, Belgium.

Andreas Paul (A)

C.U.K. GHs Essen, Essen, Germany.

Juan Carlos Garcia-Valdecasas (JC)

Hospital Clinic I Provincial de Barcelona, Barcelona, Spain.

Fernando San Juan Rodríguez (FSJ)

Hospital Universitario LA FE, Valencia, Spain.

Erica Villa (E)

Department of Gastroenterology, Policlinico of Modena University Hospital of Modena, Modena, Italy.

Patrizia Burra (P)

Multivisceral Transplant Unit, Department of Surgery, Oncology and Gastroenterology, Padua University Hospital, Padua, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH